Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Regeneron wins appeals court orders backing halt on Eylea biosimilars
4 months ago
Pharma
Law
FDA approves Axsome's acute migraine treatment after 2022 rejection
4 months ago
Pharma
FDA+
Blackstone secures $1.6B so far for new life sciences fund targeted at $5B+
4 months ago
Financing
Hims is making its Super Bowl debut with an ad that goes straight for pharma
4 months ago
Health Tech
Rentschler exits cell and gene business due to low demand, will prioritize biologics
4 months ago
People
Manufacturing
Takeda scraps programs as it raises full-year guidance
4 months ago
Pharma
Bright Green budgets $3.5B for new builds; European Commission opens biomanufacturing hub
4 months ago
Manufacturing
Cargo Therapeutics cuts lead CAR-T program, 50% of staff
4 months ago
People
R&D
Ironwood's layoffs; Shionogi’s RSV pill succeeds in Phase 2
4 months ago
News Briefing
Tectonic gets Phase 1b win in heart condition where Eli Lilly recently failed
4 months ago
R&D
How Define Ventures thinks health tech startups will exit in 2025
4 months ago
Health Tech
Takeda CEO Christophe Weber to retire in June 2026, Julie Kim to take over
4 months ago
People
Pharma
Merck stops another Winrevair study early based on positive results from earlier PAH trial
4 months ago
R&D
Roche aims for derisked deals and ruthless portfolio cuts in 2025
4 months ago
Deals
R&D
Sanofi is in the market for M&A, thanks to ‘strong’ balance sheet
4 months ago
Deals
Pharma
Inhibikase shelves Parkinson’s asset after Phase 2 flop
4 months ago
R&D
Exclusive: Fertility startup to begin Phase 3 study of stem cell therapy for IVF
4 months ago
R&D
FDA+
Teva CEO says Austedo can grow 'way beyond' impact of IRA
4 months ago
Pharma
8VC, a tech and life sciences VC firm behind Altos Labs, eyes $1B fund
4 months ago
Financing
Startups
Lonza looks to buy facilities and tech to boost service offerings
4 months ago
Deals
Manufacturing
23andMe weighs a sale as cash dwindles
4 months ago
Financing
Health Tech
Curie.Bio has a new $340M fund; Layoffs at Benchling, I-Mab
4 months ago
News Briefing
Trump administration makes first comments on how it will run IRA drug negotiations
4 months ago
Pharma
FDA+
Key GOP senator is ‘struggling’ with Kennedy nomination over vaccine answers
4 months ago
People
Pharma
First page
Previous page
48
49
50
51
52
53
54
Next page
Last page